Reply to “Methodological Concerns in ‘Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma’”
Liver Cancer · 11.06.2026 · 1-2
DOI: 10.1159/000553001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver Cancer, online erschienen am 11.06.2026. Verfasst von Da-Long Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, China. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Guangxi Medical University, Nanning, China.
Zitieren
APA
Yang, D. L., Huang, J. L., Qin, H. G., Ma, L., Zhong, J. H., & GUIDANCE Investigators (2026). Reply to “Methodological Concerns in ‘Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma’”. Liver Cancer, 1-2. https://doi.org/10.1159/000553001
Vancouver
Yang DL, Huang JL, Qin HG, Ma L, Zhong JH, GUIDANCE Investigators. Reply to “Methodological Concerns in ‘Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma’”. Liver Cancer. 2026:1-2. doi:10.1159/000553001
BibTeX
@article{Yang2026,
author = {Yang, Da-Long and Huang, Jian-Li and Qin, Hong-Gui and Ma, Liang and Zhong, Jian-Hong and GUIDANCE Investigators, GUIDANCE Investigators},
title = {Reply to “Methodological Concerns in ‘Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma’”},
journal = {Liver Cancer},
year = {2026},
pages = {1--2},
doi = {10.1159/000553001}
}
EUVIMED